The Center for Drug Discovery (CCD) was established in 2016 as a partnership between the School of Medicine and the Office of the Provost.
The impetus was the need to help bridge the so-called “Valley of Death” in drug development, which reflects declining early-stage drug discovery and development by the private sector.
By blending internationally-recognized scholarly leadership with the University’s emphasis on innovation and entrepreneurship, a goal of the CCD is to translate outstanding research into products that improve the quantity and quality of life.
The Center is anchored in the Department of Biochemistry and Molecular Biophysics.
CDD legacy institutions include the CGSC and HTC.